Denali Advisors’s GSK GSK Stock Holding History

Denali Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.5M	Sell	28,680 -633	-2%	-$33.5K	0.15%	148
2026 Q1	$1.62M	Buy	29,313 +1,440	+5%	+$78K	0.18%	132
2025 Q4	$1.37M	Buy	27,873 +8,733	+46%	+$407K	0.15%	144
2025 Q3	$826K	Sell	19,140 -12,709	-40%	-$496K	0.09%	180
2025 Q2	$1.22M	Buy	31,849 +3,072	+11%	+$117K	0.13%	154
2025 Q1	$1.11M	Buy	+28,777	New	+$1.05M	0.13%	164
2024 Q4	–	Sell	-9,543	Closed	-$390K	–	285
2024 Q3	$390K	Buy	+9,543	New	+$390K	0.04%	252

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Denali Advisors's GSK Position: Q2 2026 in Review

Denali Advisors reduced its GSK (GSK) stake by 2.2% in Q2 2026, selling an estimated $33.5K and leaving 28,680 shares worth $1.5M. The position accounts for 0.15% of the portfolio, ranked #148.

Denali Advisors first reported a position in GSK in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.62M in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Denali Advisors held 28,680 shares of GSK worth $1.5M as of Q2 2026.
Denali Advisors sold 633 GSK shares in Q2 2026, an estimated $33.5K.
GSK made up 0.15% of Denali Advisors's portfolio in Q2 2026, its #148 holding.
Denali Advisors first reported a position in GSK in Q3 2024 and has held it in 7 quarters since.
Denali Advisors's GSK position peaked at $1.62M in Q1 2026.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Denali Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.